Palvella Therapeutics Ownership & Insider Activity

Palvella Therapeutics (PVLA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.6% of shares outstanding. Institutional investors hold 54.2%. Over the past 90 days, insiders made 2 sales worth $7.7M.

Shares Outstanding

14.408M

Shares Float

12.738M

Insider Shares Owned

366.135K

Insider % Owned

2.6%

Institutional Shares Held

7.809M

Institutional % Held

54.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$7.7M total

Net Activity

Net Selling

Net Value (90d)

-$7.7M

Palvella Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 21, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$66.34	$502K
Oct 12, 2026	GEORGE JENKINS	DIRECTOR	SELL	27.500K	$130.16	$3.6M
Sep 16, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$80.17	$620K
Sep 11, 2026	GEORGE JENKINS	DIRECTOR	SELL	27.500K	$151.53	$4.2M
Sep 2, 2026	CHRISTOPHER KIRITSY	DIRECTOR	SELL-OPTIONS	—	$142.10	$9K
Aug 19, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$80.16	$620K
Jul 15, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$78.69	$607K
Jun 17, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$59.42	$441K
May 20, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$59.33	$441K